Open Access

RESIDENT’S CORNER

Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma

Abhinav V. Reddy^1,2, Matthew N. Mills^1,3, Stanley L. Liauw⁴, Sujith Baliga⁵, Charles R. Kersh⁶

1 Transitional Year Program, Riverside Regional Medical Center, Newport News, Virginia, USA
2 Department of Radiation Oncology and Molecular Sciences, Johns Hopkins Medicine, Baltimore, Maryland, USA
3 Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA
4 Department of Radiation and Cellular Oncology, University of Chicago of Medicine, Chicago, Illinois, USA
5 Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
6 Riverside and University of Virginia Radiosurgery Center, Newport News, Virginia, USA
Address correspondence to Dr. Abhinav V. Reddy, Riverside Regional Medical Center, 500 J. Clyde Morris Blvd., 2 Annex, Newport News, VA 23601 USA

Canadian Journal of Urology 2019, 26(2), 9743-9745.

Abstract

Renal cell carcinoma (RCC) is usually treated with surgery, with or without systemic therapy. For select patients, stereotactic body radiation therapy (SBRT) may be a suitable alternative. Although many reports exist on the successful use of SBRT, very few have described long term outcomes with regard to disease progression and renal function. We report a rare case of a single patient with primary, metastatic, and locally recurrent renal cell carcinoma who was successfully treated with SBRT. The patient has been disease-free for 8 years since treatment, with stable renal function even after two courses of SBRT to her solitary functioning kidney.

---

Keywords

---